Home - Blank Rome LLP

Register to receive insights and analyses on breaking news and trends across varying industries.
<a class="link-primary mt-4" href="/subscribe">Subscribe</a>

Philadelphia, PA

New York, NY

Wilmington, DE

Cincinnati, OH

Princeton, NJ

Los Angeles, CA

Houston, TX

Tampa, FL

Shanghai

South Florida

Pittsburgh, PA

Washington, D.C.

Chicago, IL

Orange County, CA

Dallas, TX

Boston, MA

Blank Rome partner <a href="/people/rachael-g-pontikes/" id="18670">Rachael G. Pontikes</a> will serve as a panel moderator at the Food and Drug Law Institute’s (“FDLI”) <a href="https://www.fdli.org/2025/05/2025-fdli-annual-conference/">2025 Annual Conference</a>, being held May 15 through 16, 2025, in Washington, D.C. Blank Rome is pleased to be a Gold Sponsor of the conference.

core/paragraph

core/heading

The FDLI Annual Conference provides an opportunity to delve into the complex legal, regulatory, compliance, and policy issues currently impacting the U.S. Food and Drug Administration (“FDA”)-regulated industry. Speakers include professionals from the federal government, industry, the private bar, non-profit organizations, patient and consumer advocacy groups, consulting organizations, and academia.

Rachael, who is a member of the conference planning committee, will moderate “Compounding, Drug Shortages, and Regulatory Challenges,” taking place on Thursday, May 15, from 3:10 to 4:10 p.m.

Moderator: Rachael G. Pontikes, Partner, Blank Rome LLP

core/list-item

Emily Thakur, Team Leader, Office of Drug Shortages, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Lee Rosebush, Chair, Outsourcing Facility Association and Partner, Baker Hostetler

Scott Brunner, CEO, Alliance for Pharmacy Compounding

core/list

For more information, the full agenda, and to register, please visit the&nbsp;<a href="https://www.fdli.org/2025/05/2025-fdli-annual-conference/">conference webpage</a>.

Compounding, Drug Shortages, and Regulatory Challenges

Offices

Stay Connected

Slide Menu

Slide Search

Compounding, Drug Shortages, and Regulatory Challenges

Offices

Stay Connected